Acutus Medical

Acutus Medical, Inc. engages in the development of medical devices and electrophy equipment. It creates electrophysiological mapping systems for the treatment of cardiac arrhythmias, such as atrial fibrillation, and ventricular tachycardia. The company was founded by Randell L. Werneth and Christoph Scharf in 2011 and is headquartered in Carlsbad, CA.

Earnings data Q2 2020

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CARLSBAD, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the first quarter of 2022 and announced a leadership transition.

Acutus Medical Reports First Quarter 2022 Financial Results and CEO Transition

Didi Global

Mullen Automotive

Check these trending penny stocks out for your watchlist The post 3 Hot Trending Penny Stocks to Watch in May 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Hot Trending Penny Stocks to Watch in May 2022

CARLSBAD, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its first quarter 2022 financial results on Thursday, May 12, 2022. In conjunction with the release, Acutus will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.

Acutus Medical to Announce First Quarter 2022 Financial Results

Acutus Medical Inc (NASDAQ: AFIB) shares are skyrocketing on a commitment letter from Deerfield Management Company to refinance its existing debt with a new longer-term credit facility. The Company has also agreed to sell its left-heart access portfolio to Medtronic plc (.

Acutus Medical Stock Soars On Debt Refinancing, Divestiture Of Left-Heart Access Portfolio

Cosmos Holdings

Kintara Therapeutics

Here's what you need to know about trading penny stocks on April 27th The post Best Penny Stocks to Buy Today? 3 Climbing In Morning Trading  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Best Penny Stocks to Buy Today? 3 Climbing In Morning Trading

CARLSBAD, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced a commitment letter from Deerfield Management Company (“Deerfield”), to refinance its existing debt with a new longer-term credit facility, and in conjunction with the refinancing, a definitive agreement to sell the Company's left-heart access portfolio to Medtronic. The combination of these two transactions, taken together with the company's recently completed restructuring, will result in a comprehensive recapitalization of the business to fund the Company's strategic growth priorities.

Acutus Medical Announces Agreements to Fund Strategic Growth Priorities

Brickell Biotech Inc

Histogen

Idera Pharmaceuticals

Synthetic Biologics

Top penny stocks to watch under $1 in April if you like Biotech stocks. The post 5 Top Biotech Penny Stocks Under $1 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

5 Top Biotech Penny Stocks Under $1 To Watch This Week

New York, New York--(Newsfile Corp. - April 18, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acutus Medical, Inc. (NASDAQ: AFIB) between May 13, 2021 and November 11, 2021, inclusive (the "Class Period") of the important April 18, 2022 lead plaintiff deadline.SO WHAT: If you purchased Acutus Medical securities during the Class Period you may be entitled to compensation without payment of any out of...

AFIB DEADLINE TODAY: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Acutus Medical, Inc. Investors to Secure Counsel Before Important April 18 Deadline in Securities Class Action - AFIB

Los Angeles, California--(Newsfile Corp. - April 18, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acutus Medical, Inc. ("Acutus" or "the Company") (NASDAQ: AFIB) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between May 13, 2021 and November 11, 2021, inclusive...

Deadline Today: The Schall Law Firm Encourages Investors in Acutus Medical, Inc. with Losses of $100,000 to Contact the Firm

NEW YORK , April 18, 2022 /PRNewswire/ -- Attention Acutus Medical, Inc. ("Acutus") (NASDAQ: AFIB) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors. This lawsuit is on behalf of all purchasers of Acutus common stock between May 13, 2021 and November 11, 2021, inclusive.

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Acutus Investors of a Lead Plaintiff Deadline of April 18, 2022

New York, New York--(Newsfile Corp. - April 16, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acutus Medical, Inc. (NASDAQ: AFIB) between May 13, 2021 and November 11, 2021, inclusive (the "Class Period") of the important April 18, 2022 lead plaintiff deadline.SO WHAT: If you purchased Acutus Medical securities during the Class Period you may be entitled to compensation without payment of any out of...

FINAL DEADLINE MONDAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Acutus Medical, Inc. Investors with Losses Over $100K to Secure Counsel Before Important April 18 Deadline in Securities Class Action - AFIB

Los Angeles, California--(Newsfile Corp. - April 15, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acutus Medical, Inc. ("Acutus" or "the Company") (NASDAQ: AFIB) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Deadline Monday Notice: The Schall Law Firm Encourages Investors in Acutus Medical, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming April 18, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ: AFIB) common stock between May 13, 2021 and November 11, 2021, inclusive (the “Class Period”). If you are a shareholder who suffered a loss, click here to participate. On November 11, 2021, Acutus announced that it was slashin

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acutus Medical, Inc. (AFIB)

NEW YORK , April 15, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Acutus Medical, Inc. (NASDAQ: AFIB). To receive updates on the lawsuit, fill out the form: https://claimyourloss.com/securities/acutus-medical-inc-loss-submission-form/?id=25954&from=4 This lawsuit is on behalf of all purchasers of Acutus common stock between May 13, 2021 and November 11, 2021, inclusive.

AFIB SHAREHOLDER ALERT: Jakubowitz Law Reminds Acutus Shareholders of a Lead Plaintiff Deadline of April 18, 2022

Los Angeles, California--(Newsfile Corp. - April 14, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acutus Medical, Inc. ("Acutus" or "the Company") (NASDAQ: AFIB) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Deadline Monday Reminder: The Schall Law Firm Encourages Investors in Acutus Medical, Inc. with Losses of $100,000 to Contact the Firm

New York, New York--(Newsfile Corp. - April 14, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acutus Medical, Inc. (NASDAQ: AFIB) between May 13, 2021 and November 11, 2021, inclusive (the "Class Period") of the important April 18, 2022 lead plaintiff deadline.SO WHAT: If you purchased Acutus Medical securities during the Class Period you may be entitled to compensation without payment of any out of...

AFIB FINAL DEADLINE MONDAY: ROSEN, A LONGSTANDING LAW FIRM, Encourages Acutus Medical, Inc. Investors with Losses to Secure Counsel Before Important April 18 Deadline in Securities Class Action - AFIB

LOS ANGELES , April 14, 2022 /PRNewswire/ --  Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ: AFIB). Class Period: May 13, 2021 – November 11, 2021 Lead Plaintiff Deadline: April 18, 2022 If you wish to serve as lead plaintiff of the Acutus lawsuit, you can submit your contact information at www.glancylaw.com/cases/acutus-medical-inc/.

AFIB Investors Have Opportunity to Lead Acutus Medical, Inc. Securities Fraud Lawsuit

NEW YORK , April 14, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ: AFIB) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Acutus investors who were adversely affected by alleged securities fraud.

AFIB LAWSUIT ALERT: Levi & Korsinsky Notifies Acutus Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

SAN DIEGO, April 14, 2022 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announced that purchasers of Acutus Medical, Inc. (NASDAQ: AFIB) common stock between May 13, 2021 and November 11, 2021, inclusive (the "Class Period") have this upcoming Monday, April 18, 2022 to seek appointment as lead plaintiff in the Acutus Medical class action lawsuit.  Robbins Geller represents the plaintiff in the first-filed complaint, Brown v.

MONDAY DEADLINE: Acutus Medical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Los Angeles, California--(Newsfile Corp. - April 13, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acutus Medical, Inc. ("Acutus" or "the Company") (NASDAQ: AFIB) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Monday Deadline Notice: The Schall Law Firm Encourages Investors in Acutus Medical, Inc. with Losses of $100,000 to Contact the Firm

NEW YORK , April 13, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Acutus Medical, Inc.. Shareholders who purchased shares of AFIB during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Acutus Medical, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 18, 2022 - (NASDAQ: AFIB)

San Diego, California--(Newsfile Corp. - April 12, 2022) - The Shareholders Foundation, Inc. announced that a deadline is coming up on April 18th in the lawsuit that was filed for certain investors in (NASDAQ: AFIB) shares.Investors who have losses of over $50,000 from their investment in shares of Acutus Medical, Inc. (NASDAQ: AFIB) from purchases between May 13, 2021 and November 11, 2021, have certain options. NASDAQ: AFIB investors should contact the Shareholders Foundation at...

NOTICE For Investors In NASDAQ: AFIB: April 18th Deadline in Lawsuit against Acutus Medical, Inc. announced by Shareholders Foundation

NEW YORK , April 12, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Acutus Medical, Inc. (NASDAQ: AFIB) alleging that the Company violated federal securities laws. This lawsuit is on behalf of all purchasers of Acutus common stock between May 13, 2021 and November 11, 2021, inclusive.Lead Plaintiff Deadline: April 18, 2022 No obligation or cost to you.

AFIB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 18, 2022 in the Class Action Filed on Behalf of Acutus Medical, Inc. Shareholders

NEW YORK , April 10, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acutus Medical, Inc. (NASDAQ: AFIB) between May 13, 2021 and November 11, 2021, inclusive (the "Class Period") of the important April 18, 2022 lead plaintiff deadline. SO WHAT: If you purchased Acutus Medical securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

FINAL DEADLINE NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Acutus Medical, Inc. Investors with Losses to Secure Counsel Before Important April 18 Deadline in Securities Class Action - AFIB

New York, New York--(Newsfile Corp. - April 9, 2022) - Pomerantz LLP announces that a class action lawsuit has been filed against Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ: AFIB) and certain of its officers. The class action, filed in the United States District Court for the Southern District of California, and docketed under 22-cv-00388, is on behalf of a class consisting of all purchasers of Acutus common stock between May 13,...

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acutus Medical, Inc., of Class Action Lawsuit and Upcoming Deadline - AFIB

News for Acutus Medical Stock (AFIB)